Avance Life Sciences UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
0 |
- |
0 |
0 |
- |
- |
- |
- |
- |
0 |
0 |
0 |
0 |
2023 |
---|
0 |
- |
0 |
0 |
- |
- |
0.02 |
- |
- |
1,000 |
20 |
0 |
1,020 |
2024 |
---|
59,000 |
29,500 |
993 |
830 |
415 |
0.03 |
0.63 |
100.00 |
1.41 |
1,830 |
1,157 |
0 |
2,987 |
Register and
explore Okredo data2024 |
---|
59,000 |
29,500 |
993 |
830 |
415 |
0.03 |
0.63 |
100.00 |
1.41 |
1,830 |
1,157 |
0 |
2,987 |
Register and
explore Okredo data2024
Turnover (€)
59,000 €- *
Sales per employee (€)
29,500 €- *
Profit before tax (€)
993 €- *
Net Profit (€)
830 €- *
Profit per employee (€)
415 €- *
Working capital requirement
0.03 - *
Debt-to-equity ratio
0.63 3,050.00 % *
Total profitability (%)
100.00 %- *
Net profitability (%)
1.41 %- *
Equity (€)
1,830 €83 % *
Amounts Payable And Liabilities (€)
1,157 €5,685 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
2,987 €193 % *